Early Therapeutic Intervention for IgG4-related Dacryoadenitis and Sialadenitis: The Balance Between Risk of Observation Only and Therapeutic Adverse Effects

J Rheumatol. 2018 Aug;45(9):1339-1340. doi: 10.3899/jrheum.180163.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • Dacryocystitis / drug therapy*
  • Dacryocystitis / immunology
  • Disease Progression
  • Female
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunoglobulin G4-Related Disease / drug therapy*
  • Immunoglobulin G4-Related Disease / immunology
  • Male
  • Middle Aged
  • Prednisolone / adverse effects*
  • Prednisolone / therapeutic use
  • Sialadenitis / drug therapy*
  • Sialadenitis / immunology
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Prednisolone